|
|
PVCT Provectus Biopharmaceuticals
|
|
||
My viewI already PM some of you on this here is my view point on what can happen. I figure I will open up a can of worms as there seems to be nothing else to talk about besides a five cent share price. Of the six trials we have going I don't believe the following trials will be completed prior to 2Q 2021. So essential we need another 1.5 to 2 years for: - Expanded P1 combo (48 patients) - Liver - NETs, - PEDs studies, - yet to be started P2 PH-10 trials As of today we have in dollars $32mm worth of potential warrants that could be exercised and fill the coffers with cash.
Both the PVCTW and $1 warrants expire in June 2020. These warrants are already are factored in. Essentially the next raise is built in to the share price on one one condition. We need major news such as an indication for MUM or NETs prior to June 2020. If so, the MRW would no longer depress the SP. In addition there would be overnight credibility with the street as well. No longer would BP have any leverage as the company could start new trials, accelerate existing ones and maybe a small company buy back to nullify the Maxim raise. This could be the leverage we need if true. As Vorlon points out MUM is the only indication NOT moving to P2. Perhaps the group knows they have a shot at BTD, AA, FT or whatever by June 2020. If so we are golden. If not then I side with CS as this may take another couple years for them to run the P2 trials. There is no point in giving news after 1Q 2021 and in 2Q as the MRW will expire in August reducing the share count by almost 20%. My guess is we will receive news early 1Q 2021 or September 2021 or later. So there you have it. Hack away.... |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
4582 | Re: My view | Atlas | 3 | 8/21/2019 8:55:11 PM |
4583 | Re: My view | leave_the_gun | 5 | 8/22/2019 12:05:05 PM |
4584 | Re: My view | Take_The_Canolis | 2 | 8/22/2019 12:08:17 PM |